HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestle LC1 Probiotic Supplement Launching With Direct Mail, Print Support

This article was originally published in The Tan Sheet

Executive Summary

Nestle USA is introducing its first dietary supplement product, Nestle LC1, with print ads and direct mail support expected to break the week of March 5.

You may also be interested in...



Nestle

Probiotic supplement LC1 discontinued due to lower-than-expected sales, firm says. Nestle stopped selling the supplement in November, although the probiotic is still available as a chilled dairy product or yogurt in some countries. Company speculates powder form of LC1 might have kept sales down but says it has no plans for U.S. reintroduction in a different form. The Lactobacillus johnsonii-containing powder launched in March at GNC stores and drugstore.com (1"The Tan Sheet" March 6, 2000, p. 4)

GasAid, Probiotica "From The Makers Of Imodium" Launching Now

Maximum Strength GasAid and Probiotica Daily Dietary Supplement, with principal display panels noting both are "from the makers of Imodium," are arriving now in food, drug and mass outlets nationwide, according to McNeil Consumer Healthcare.

Probiotic Definition, GMPs Discussed By Food Advisory Committee

FDA needs to better define the probiotics category and specify appropriate Good Manufacturing Practices, Food Advisory Committee members recommended at a recent meeting in Arlington, Va.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133896

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel